<strong>Screening</strong> and diagnostic testsand, hence, optimise d<strong>et</strong>ection, a radioactive probewhich is compatible with restriction enzyme choiceis recommended (Rousseau <strong>et</strong> <strong>al</strong>, 1992).A simplified profile of the DNA banding patternproduced from a double digest is shown in Figure 4.Norm<strong>al</strong> m<strong>al</strong>es have a single band whereas, infem<strong>al</strong>es, a second band is seen representing them<strong>et</strong>hylated, inactivated X chromosome. A fourbandedpattern is produced by a fem<strong>al</strong>e with aPM, since she will have the mutated and norm<strong>al</strong> Xchromosome in both the inactive and active state.In m<strong>al</strong>es, a m<strong>et</strong>hylated band is seen only <strong>for</strong> an FM.Southern blotting has sever<strong>al</strong> disadvantages inthe screening context. First, it cannot be usedto d<strong>et</strong>ermine accurately the repeat size, which isimportant <strong>for</strong> sm<strong>al</strong>l PMs. Second, there is a longlaboratory turn-round time of up to 10 days, largelybecause of the radioactive d<strong>et</strong>ection of fragments;using a phospho-imaging d<strong>et</strong>ection system (such asthat produced by Molecular Synth<strong>et</strong>ics Ltd) couldreduce turn-round time to 1 day. Third, the test isexpensive at about £50–75 per test.DNA amplification by polymerasechain reactionA rapid and relatively cheap m<strong>et</strong>hod of assessingthe repeat size is to amplify part of the DNA.The most common technique is the polymerasechain reaction (PCR), in which the enzyme DNApolymerase is used to process and copy a specifiedsequence. The PCR product can be d<strong>et</strong>ected byradioactive (Fu <strong>et</strong> <strong>al</strong>, 1991; Pergolizzi <strong>et</strong> <strong>al</strong>, 1992;Erster <strong>et</strong> <strong>al</strong>, 1992) or other means (Brown <strong>et</strong> <strong>al</strong>,1993; El-Aleem <strong>et</strong> <strong>al</strong>, 1995; Nanba <strong>et</strong> <strong>al</strong>, 1995;Haddad <strong>et</strong> <strong>al</strong>, 1996; Wang <strong>et</strong> <strong>al</strong>, 1995a). Thus, them<strong>et</strong>hod works on sm<strong>al</strong>ler quantities of less purifiedstarting materi<strong>al</strong>, either blood or mouthwash(Hagerman <strong>et</strong> <strong>al</strong>, 1994a), than Southern blotting.The turn-round time <strong>for</strong> PCR testing is approximately1 week and, <strong>for</strong> a high throughput, thecost may be reduced to £10 per sample.PCR is most suitable <strong>for</strong> d<strong>et</strong>ecting PMs and largenorm<strong>al</strong> <strong>al</strong>leles as it enables improved size resolutionof sm<strong>al</strong>l repeat sequences (Heitz <strong>et</strong> <strong>al</strong>, 1992;Macpherson <strong>et</strong> <strong>al</strong>, 1992a). Its use is limited <strong>for</strong> thed<strong>et</strong>ection of large FMs, and it is unable to d<strong>et</strong>erminem<strong>et</strong>hylation status. There is a tendency <strong>for</strong>large FMs to fail to amplify. This is less of a problemin m<strong>al</strong>es since absence of an expanded fragmentcan be taken to indicate that an FM may be presentand demonstration of a sm<strong>al</strong>l repeat size is sufficientto exclude an FM. In fem<strong>al</strong>es, however, theabsence of one of the two bands expected afterPCR an<strong>al</strong>ysis is ambiguous. A sm<strong>al</strong>l single band isconsistent with(a) preferenti<strong>al</strong> amplification of the sm<strong>al</strong>ler oftwo <strong>al</strong>leles, one of which might be mutated(Brown <strong>et</strong> <strong>al</strong>, 1993; Erster <strong>et</strong> <strong>al</strong>, 1992; Pergolizzi<strong>et</strong> <strong>al</strong>, 1992)(b) norm<strong>al</strong> <strong>al</strong>leles homozygous <strong>for</strong> size(c) norm<strong>al</strong> <strong>al</strong>leles differing by only one CGGrepeat, which are practic<strong>al</strong>ly indistinguishable.Brown and colleagues (1993) have devised am<strong>et</strong>hodology which avoids selective amplificationof the sm<strong>al</strong>ler <strong>al</strong>lele in h<strong>et</strong>erozygotes enablingthem to be differentiated from homozygotes.However, a single <strong>al</strong>lele on PCR is still notfully in<strong>for</strong>mative.PCR and selectiveSouthern blottingSequenti<strong>al</strong> testing is a reasonable compromiseb<strong>et</strong>ween Southern blotting and PCR. The protocol5.2 kb2.8 kbNorm<strong>al</strong>fem<strong>al</strong>eNorm<strong>al</strong>m<strong>al</strong>ePMfem<strong>al</strong>ePMm<strong>al</strong>eFMfem<strong>al</strong>eFMm<strong>al</strong>eFM m<strong>al</strong>emosaic30FIGURE 4 Example of test results using a double digest
He<strong>al</strong>th Technology Assessment 1997; Vol. 1: No. 4is to per<strong>for</strong>m PCR on <strong>al</strong>l samples but when thereis a failure to amplify or there is a single band ina fem<strong>al</strong>e to per<strong>for</strong>m a Southern blot. Over onequarterof fem<strong>al</strong>es are homozygous <strong>for</strong> repeat size(see Table 2) and, in our experience, a further 8%have <strong>al</strong>leles differing by one repeat. Thus, thisapproach requires a fair amount of Southernblotting, adding an extra week to the turn-roundtime and, thus, addition<strong>al</strong> costs.Blotting PCR productsAlthough FMs are amplified inefficiently, theirlarge expansions become ide<strong>al</strong> hybridisationtarg<strong>et</strong>s <strong>for</strong> CGG containing oligonucleotides.Blotting m<strong>et</strong>hods <strong>for</strong> these PCR products havebeen described <strong>for</strong> fragile X syndrome. Becaus<strong>et</strong>he initi<strong>al</strong> reaction uses DNA amplification, onlysm<strong>al</strong>l amounts of starting materi<strong>al</strong> are required.Non-radioactive blotting of amplified productsis feasible (Pergolizzi <strong>et</strong> <strong>al</strong>, 1992).PCR-based m<strong>et</strong>hylation assayThis m<strong>et</strong>hod relies on the fact that the unm<strong>et</strong>hylatedFMR-1 gene can be digested by certainenzymes, whereas the m<strong>et</strong>hylated gene is resistantto digestion. Thus, in m<strong>al</strong>es, where m<strong>et</strong>hylationoccurs with an FM but not a PM or norm<strong>al</strong> <strong>al</strong>lele,digestion with a m<strong>et</strong>hylation-sensitive enzymefollowed by amplification should only yieldproducts if there is an FM. Fem<strong>al</strong>es with an FMare not d<strong>et</strong>ected by this m<strong>et</strong>hod since they <strong>al</strong>wayshave one of their X chromosomes m<strong>et</strong>hylated(Wang <strong>et</strong> <strong>al</strong>, 1995a). There is <strong>al</strong>so the risk ofincompl<strong>et</strong>e digestion.Measurement of FMRPAn antibody test has been described to measureFMRP (Willemsen <strong>et</strong> <strong>al</strong>, 1995). This could be usedto d<strong>et</strong>ect an FM in m<strong>al</strong>es since those affected shouldproduce no protein. The test will not be useful infem<strong>al</strong>es since protein is produced from the norm<strong>al</strong>active X chromosome even when the other chromosomehas an FM. Also, even <strong>for</strong> m<strong>al</strong>es the test islimited, because mosaics produce FMRP to a degree.PM <strong>al</strong>leles yield norm<strong>al</strong> quantities of FMRP.Alternatives to standard PCRSever<strong>al</strong> <strong>al</strong>ternative m<strong>et</strong>hods to standard PCR havebeen described, <strong>al</strong>though none are in routine use.Repeat expansion d<strong>et</strong>ectionFirst described by Sch<strong>al</strong>ling and colleagues (1992),repeat expansion d<strong>et</strong>ection (RED) uses a thermostableDNA ligase in the usu<strong>al</strong> cycling reaction.Complementary oligonucleotides are used, whichanne<strong>al</strong> <strong>al</strong>ong the entire length of one strand ofthe repeat sequence. Adjacent oligonucleotidesare then joined by adding ligase. The ligatedproducts from one cycle continue to ligate toproducts generated from the origin<strong>al</strong> DNA in <strong>al</strong>lsubsequent cycles, until the whole expansion hasbeen replicated. However, sensitivity is rather poorin comparison with PCR because the techniqueinvolves no amplification.Ligase chain reactionThe ligase chain reaction (LCR) does <strong>al</strong>low amplificationbut to date has gener<strong>al</strong>ly been restrictedto the mapping of point mutations involving thegeneration of short str<strong>et</strong>ches of DNA. LCR is lesssuited to the amplification of longer str<strong>et</strong>ches ofDNA because of its reliance on complementaryself-anne<strong>al</strong>ing primers. It has an advantage overPCR in that it is a non-processive system andshould not show undue bias against the d<strong>et</strong>ectionof large expansions.HybridsA m<strong>et</strong>hod combining LCR and PCR has beendescribed by both Abbott Laboratories Ltd andRoche Diagnostics Ltd <strong>for</strong> the d<strong>et</strong>ection of microorganisms,and this may adapt well to d<strong>et</strong>ectingCGG amplifications <strong>al</strong>though it has not as y<strong>et</strong> beentried. A modified RED with the hybrid PCR–LCRd<strong>et</strong>ection system is another possibility.Testing protocolsGiven the technic<strong>al</strong>, practic<strong>al</strong> and financi<strong>al</strong>constraints of the various laboratory techniquesavailable, it is possible to devise a reasonabl<strong>et</strong>esting protocol <strong>for</strong> the main applications.<strong>Screening</strong>For antenat<strong>al</strong>, pre-conceptu<strong>al</strong>, cascade andneonat<strong>al</strong> screening, the first choice would bePCR followed by selective Southern blottingof ambiguous <strong>al</strong>leles. Since antenat<strong>al</strong> and preconceptu<strong>al</strong>screening concentrate on fem<strong>al</strong>es,one-third of samples may <strong>al</strong>so need Southernblotting, thus increasing the average cost oftesting to about £30 per sample. Non<strong>et</strong>heless,this would offer a cheaper, faster and moreaccurate <strong>al</strong>ternative to Southern blotting of <strong>al</strong>lsamples. A more sophisticated protocol wouldinvolve the sequencing of grey zone <strong>al</strong>leles <strong>for</strong>31